Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Are peptides legal in Missouri?

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

The short answer

Yes. A Missouri resident can obtain FDA approved peptides such as semaglutide and tirzepatide from a Missouri-licensed physician, including by telehealth, but Missouri's telehealth statute (RSMo 191.1146, as amended effective August 28, 2026) requires a properly established physician-patient relationship, an evaluation, a medical history review, and an examination sufficient for diagnosis before prescribing, and it accepts a patient questionnaire only when the treating health care professional reviews it and it holds enough information to stand in for an in-person evaluation. A second statute (RSMo 334.108) bars prescribing based solely on a telemedicine evaluation unless a previously established and ongoing physician-patient relationship exists, so Missouri law does not settle whether a questionnaire or other visit that is not live can support a prescription by itself. A compounded peptide is available when it is eligible under federal 503A rules and dispensed by a pharmacy licensed by the Missouri Board of Pharmacy; out-of-state pharmacies need a Missouri nonresident pharmacy license (20 CSR 2220-2.025).

Regulatory: Telehealth allowedRegulatory: Async unclearRegulatory: Compounded GLP-1 limitedVerified: Verified Oct 28, 2026
Compounding rules
Follows the federal 503A framework
Telehealth prescribing
Allowed, asynchronous unclear
Compounded GLP-1
Limited

Can a Missouri resident get peptides by telehealth?

RSMo 191.1145 defines telehealth or telemedicine to include asynchronous store-and-forward technology and holds it to the in-person standard of care. RSMo 191.1146 requires a physician using telemedicine to ensure a properly established physician-patient relationship, which can be formed in person, through consultation with a physician who has an existing relationship, or through a telemedicine encounter if the standard of care does not require an in-person visit. 2026 House Bill 2372 amended RSMo 191.1146 and 334.108 effective August 28, 2026. Under the amended 191.1146, a questionnaire completed by the patient online or by telephone counts as an acceptable evaluation only if the treating health care professional reviews it and it contains enough information to stand in for an in-person evaluation. A provider who uses a questionnaire to establish the relationship must be employed by or contracted with a business entity licensed to provide health care in Missouri, and must send a written report to the patient's primary care provider, if the patient names one, within 14 days. The amended 334.108 repealed the old ban on prescribing from an internet questionnaire, but its subsection 3, which used to cover telephone evaluations, now bars prescribing based solely on an evaluation through telemedicine unless a previously established and ongoing physician-patient relationship exists. The questionnaire provisions in 191.1146 and the telemedicine bar in 334.108 subsection 3 came from the same 2026 bill. This record leaves asynchronous prescribing unconfirmed because the two provisions conflict: 191.1146 allows a relationship formed by a reviewed questionnaire, and 334.108 subsection 3 does not say whether that relationship satisfies it. For the same reason this record does not say whether a questionnaire alone is enough to prescribe. [2] [3] [4] [5]

How does the Missouri pharmacy board treat compounding?

Compounding regulator for Missouri
BoardMissouri Board of Pharmacy (Division of Professional Registration)
Eligible substancesFollows the federal 503A framework

The Missouri Board of Pharmacy licenses pharmacies under RSMo chapter 338 and regulates practice through 20 CSR 2220, including 20 CSR 2220-2.200 (sterile compounding), which sets standards for handling, labeling, distributing, and dispensing compounded sterile preparations, and 20 CSR 2220-2.400 (compounding standards of practice), which defines compounding and sets compounding guidelines. Under 20 CSR 2220-2.025, pharmacies outside Missouri that dispense and ship drugs to Missouri patients must hold a Missouri nonresident pharmacy license. Missouri has no state bulks list; peptide eligibility follows the federal 503A framework. [1] [6] [7] [8] [9] [11]

Can you get compounded GLP-1s in Missouri?

Regulatory: Compounded GLP-1 limited

Missouri requires a real clinical evaluation before a telehealth GLP-1 prescription. Since August 28, 2026 a questionnaire counts as an evaluation only when a treating health care professional reviews it and it holds enough information to stand in for an in-person evaluation. RSMo 334.108 also bars prescribing based solely on a telemedicine evaluation unless a previously established and ongoing physician-patient relationship exists. The statutes do not say how these two rules fit together, so whether a questionnaire alone can support a prescription is unsettled. The dispensing pharmacy needs a Missouri or Missouri nonresident license. [3] [4] [7] [14]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in Missouri?

Access options

We may earn a commission from these links.

Prices are the partner's own and are not verified by PeptideAgent. You answer health questions after checkout, and the partner's clinician decides whether to prescribe.

Unsponsored access paths are checked against public regulatory records. Sponsored offers are the partner's and are labeled. Products labeled research use only are never listed.

Find a provider in Missouri

What you'll actually find in Missouri, and how to check

Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. [18] [19] [20]

No FDA oversight of the specific product: FDA does not check a compounded drug's safety, effectiveness, or quality before it is sold. [21]

What Missouri has done

PeptideAgent has not found a board or legislative action on peptides in Missouri.

Other states have acted:

  • On August 19, 2026, Mississippi's medical, nursing, and pharmacy boards said no licensed provider may prescribe, recommend, supply, or administer a peptide that is not FDA approved, and that a consent form does not remove the provider's liability. [23] Mississippi law
  • Louisiana acted by statute: Act 374, in effect August 1, 2026, bars its licensing boards from prohibiting peptides only when they come from a pharmacy or outsourcing facility that complies with federal compounding law. It does not make any peptide eligible to compound. [24] [25] Louisiana law

Checking the prescriber

Telehealth prescribing of non-controlled peptides is permitted in Missouri. The state law we checked does not settle whether a prescription can be issued without a live visit, so expect one. [2] [3] [4] [5] The telehealth rule in full.

Checking the pharmacy

Look the pharmacy up yourself before you pay, including an out-of-state mail-order pharmacy. The pharmacy regulator is the Missouri Board of Pharmacy (Division of Professional Registration); its license search: FDA BeSafeRx: state board of pharmacy license lookups. [22]

If you're going ahead anyway

These steps lower some risks. They do not make a compounded product safe, and FDA has not reviewed it. [21]

They do not change a peptide's legal status either. That depends on the peptide: for a withdrawn nomination such as BPC-157 or TB-500, a 503A pharmacy has no federal basis to compound it from bulk, with or without a prescription, while a few Category 1 substances, such as NAD+ and glutathione, are compounded under FDA's interim policy, with conditions. Each peptide page gives its status. [12] [26] [27]

Check the pharmacy's license. Look the pharmacy up yourself on your state board of pharmacy's license search; FDA's BeSafeRx page links every state's. If the pharmacy is not listed, or is not licensed in your state, do not use it. [22] [28] [29]

What a legitimate prescription and consult look like. Federal law lets a pharmacy compound only for an identified patient on a valid prescription. A legitimate prescriber is licensed in the state where you are, evaluates you, and tells you the drug is compounded and not FDA approved, and a telehealth company should say which pharmacy compounds it. A seller that needs no prescription, or a pharmacy with no pharmacist to answer questions, is a warning sign. [20] [29] [30]

Why this is safer than a research-use-only product. A state-licensed pharmacy answers to its state board and has a pharmacist you can reach. A product labeled "research use only" or "not for human consumption" has neither, and FDA treats such products sold for people as unapproved drugs. In a 2024 study of semaglutide sold online without a prescription, half of six orders never arrived, and every vial that did was rated probably substandard or falsified, held more drug than its label said, and contained endotoxin. Black-market growth peptides have also contained modified molecules the label did not name. Safer is not safe: compounded drugs can also be contaminated or have too much or too little active ingredient. [21] [31] [32] [33] [34] [35]

Check for:

  • A 503A pharmacy licensed in your state (your state board of pharmacy publishes license lookups). [21]
  • A real evaluation by a licensed prescriber, not just an online form.
  • A certificate of analysis for the specific batch.

Questions to ask

  • Pharmacy: What is your license number, and are you licensed in my state? Then check it yourself on the state board's site. [22]
  • Telehealth company: Which pharmacy compounds and ships this, and is it a 503A pharmacy or a 503B outsourcing facility? [20]
  • Pharmacy: Is this made for me on a prescription written in my name? [30]
  • Prescriber: Are you licensed where I am, and will you evaluate me yourself rather than rely on a questionnaire? [20] [29]
  • Anyone offering it: Does anyone call it "FDA approved", "generic", or from an "FDA-approved pharmacy"? None of these is true of a compounded drug, so the claim is a red flag. [20]

What is offered for a specific peptide, and what FDA found, is on each peptide page.

Is it legal to buy research peptides in Missouri?

Missouri food and drug law (RSMo chapter 196) prohibits selling adulterated or misbranded drugs, and chapter 338 limits dispensing of prescription drugs to licensed pharmacies. [6] [10] [15]

Peptide-specific notes for Missouri

Peptide-specific notes for Missouri
PeptideNote
SemaglutideAvailable branded by prescription. RSMo 191.1146 sets the evaluation and examination needed for telehealth, but RSMo 334.108 bars prescribing based solely on a telemedicine evaluation without a previously established and ongoing physician-patient relationship, so a new patient's telehealth-only prescription is not settled by Missouri law. Compounded semaglutide is limited to the federal patient specific exception since April 22, 2025. [3] [4] [14]

Frequently asked questions

Can I get a GLP-1 prescription in Missouri from an online questionnaire?

Missouri law does not settle it. Since August 28, 2026, RSMo 191.1146 accepts a questionnaire as an evaluation only if the treating health care professional reviews it and it contains enough information to stand in for an in-person evaluation, and the provider must work for or contract with an entity licensed to provide health care in Missouri. But RSMo 334.108 bars prescribing based solely on a telemedicine evaluation unless a previously established and ongoing physician-patient relationship exists, and the statutes do not say which one controls. An unreviewed form does not count as an evaluation under RSMo 191.1146. [3] [4] [5]

Can a telehealth visit start a new physician-patient relationship in Missouri?

Yes, if the standard of care does not require an in-person encounter and the visit follows evidence-based telemedicine practice guidelines. The physician must be licensed in Missouri. Prescribing is a separate question. RSMo 334.108 bars prescribing based solely on a telemedicine evaluation unless a previously established and ongoing physician-patient relationship exists, and the law does not say how the two rules fit together. [3] [4]

Can an out-of-state pharmacy ship compounded peptides to me in Missouri?

Only with a Missouri nonresident pharmacy license under 20 CSR 2220-2.025. Check the Division of Professional Registration license search before ordering. [1] [7]

Can a Missouri pharmacy compound BPC-157?

Only under a draft federal policy, and only within strict limits. On October 28, 2026 HHS released a draft enforcement discretion policy saying it will not take enforcement action against a state-licensed pharmacy that compounds BPC-157 as a single-ingredient product by an allowed route, on a patient-specific prescription, from an FDA-registered manufacturer's substance with a tested certificate of analysis, with serious adverse events reported to FDA. BPC-157 is still not FDA approved or on the 503A bulks list, the policy is not binding and HHS may revisit it, and blends such as Wolverine are not covered. FDA's drug center recommended against listing BPC-157; the advisory committee voted in favor (HHS policy, Appendix B). State law still applies: Missouri has no state bulks list; peptide eligibility follows the federal 503A framework. [11] [12] [13] [16] [17]

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, federal FDA guidance, and the FDA warning letters and studies behind what is offered.

  1. [1]Missouri Board of Pharmacy
  2. [2]RSMo 191.1145, Definitions; telehealth services authorized, when
  3. [3]RSMo 191.1146, Physician-patient relationship required for telemedicine, how established
  4. [4]RSMo 334.108, Telemedicine or internet prescriptions, physician-patient relationship required
  5. [5]Missouri HB 2372 (2026) bill summary, health care and telehealth questionnaires (enacted; amended RSMo 191.1146 and 334.108 effective August 28, 2026)
  6. [6]RSMo chapter 338, Pharmacists and pharmacies
  7. [7]20 CSR 2220-2.025, Nonresident pharmacies
  8. [8]20 CSR 2220-2.200, Sterile compounding
  9. [9]20 CSR 2220-2.400, Compounding standards of practice
  10. [10]RSMo chapter 196, Food, drugs and tobacco

Cite this page

Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.

APA style
PeptideAgent. (2026, October 28). Are peptides legal in Missouri?. https://peptideagent.ai/legal/missouri
HTML link
<a href="https://peptideagent.ai/legal/missouri">Are peptides legal in Missouri?</a>, PeptideAgent, updated October 28, 2026.